Why is early goal-directed therapy successful – is it the technology? by Chapman, Martin et al.
307 EGDT = early goal-directed therapy; ScvO2 = central venous oxygen saturation.
Available online http://ccforum.com/content/9/4/307
When assessing outcome studies, the beneficial portion of
any therapeutic strategy may not be clearly identified,
especially in a condition as complex as sepsis. In the
randomized controlled trial conducted by Rivers and
coworkers [1], early goal-directed therapy (EGDT) was
associated with significantly improved outcomes in sepsis.
The study group received a package of care that focused on
early resuscitation for the first 6 hours as an inpatient. This
comprised fluid, including blood, pressors and inotropes. The
goals of resuscitation were based on hemodynamic variables
and central venous oxygen saturation (ScvO2). The
technology used to measure this was a central venous
catheter with integrated oximetry. This device is examined in
this issue of Critical Care [2]. In keeping with the style we
previously adopted for technology assessment reviews, the
article begins with a Q&A from the industry.
Early resuscitation in sepsis is standard practice [3]. If the
treatment effect reported by Rivers and coworkers is not due to
bias in the study design, then to what part(s) of the resuscitation
‘package’ is the benefit attributable? Opinions vary regarding
the contribution an oximetric catheter makes in severe sepsis
[4]. Previous studies of therapy directed by mixed venous
saturation have found no similar improvement in outcome [5,6].
It seems more likely to us that the timing of resuscitation is the
crucial aspect rather than the technology employed [7,8].
Another aspect of the study by Rivers and colleagues that
has attracted discussion is the difference in the use of blood
transfusion between the groups. The use of blood to improve
oxygen delivery is controversial; a liberal transfusion strategy
is not beneficial in general intensive care patients [9] and the
ability of stored red cells to improve oxygen delivery acutely is
known to be impaired [10]. Finally, although blinding in a trial
of resuscitation is very difficult to achieve, unfortunately the
capacity for this methodological shortcoming to introduce
bias remains undiminished.
In light of these considerations, we present a review, paired
with the Q&A, which forms part of a process of critical review
that any new health technology should be subjected to by the
critical care community. In our view, we must remain critical;
ScvO2 monitoring cannot be assumed to be central to the
success of EGDT [11]. Other goals are presented in the
review that are feasible and less invasive. It will take time for
ScvO2 monitoring to find its rightful place.
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